company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4548000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4548000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,188000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,425000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13167000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8006000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8006000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7500000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7464000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7464000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,145000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,146000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,146000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-396000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8563000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8563000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-33180000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24264000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24264000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,33180000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,354000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4281000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1792000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1792000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,186000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2130000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9576000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5468000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5468000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5555000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5540000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5540000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,73000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4013000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4013000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,185000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,347000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8950000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4405000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4405000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-63000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4250000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4148000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4148000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,129000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,150000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,150000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-107000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19746000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19746000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-444000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,29845000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9672000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-14260000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4588000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-263916000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,268764000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4846000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4846000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-22000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,258000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1272000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1272000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,177000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,385000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3315000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4025000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4025000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3985000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3950000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3950000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-75000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4265000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4265000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,171000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,313000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-666000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4447000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4447000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4000000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3964000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3964000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-477000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3859000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3859000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,180000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3335000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,842000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8216000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-9843000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1627000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1500000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1469000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1469000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,74000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-6000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,37000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,105000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,105000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-53000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4069000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4069000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,24000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3519000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3037000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4527000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,1355000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3172000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-203688000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,207700000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3941000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3941000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,28000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,798000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-296000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-296000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,146000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,495000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2488000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2143000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-2442000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4585000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-111000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4000000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3860000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3860000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,158000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,158000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,158000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-567000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1812000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1812000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,125000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,246000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,718000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-723000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-1774000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2497000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-187000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2600000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2388000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2388000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,401000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,401000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,401000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,292000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2235000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2235000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-270000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1086000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,881000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-2206000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1325000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-156000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2527000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1686000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-997000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-997000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,74000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2470000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2544000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2544000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,222000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1220000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1220000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,314000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-209000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,123000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-992000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-3870000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4862000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60059000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,47071000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,19419000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6357000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6357000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-880000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-880000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-880000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,615000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,539000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-611000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-611000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,214000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,983000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5357000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4771000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-799000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5570000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-127000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4873000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4873000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,623000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,623000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,623000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-74000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1377000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1377000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,267000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,871000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2874000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-359000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-359000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-345000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20392000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22221000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1484000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1484000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,371000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,371000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,371000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1496000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,422000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1164000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1164000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,280000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7308000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9297000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-545000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-545000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-192000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32527000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30681000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2038000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2038000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,442000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,442000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,442000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2141000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1572000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1919000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1919000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,303000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2631000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8347000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8347000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-406000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77062000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,94056000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,6198000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22786000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22786000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-554000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,351000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-203000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-203000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14236000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,430000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36376000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36376000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,185000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16343000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18120000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1728000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1728000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,16000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,28597000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-26755000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-18000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1840000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1840000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,348000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-6891000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-224000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6767000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6767000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6655000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,29000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1637000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1637000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,176000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,246000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3025000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4240000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4240000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-67000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3251000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2440000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2440000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,128000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,128000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,128000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1672000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,486000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1791000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-378000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-378000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-133000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1505000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2480000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,842000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,842000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,464000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,173000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8278000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2366000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2019000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2019000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-518000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14904000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15012000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-410000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-410000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1609000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1906000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1906000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,170000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1179000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3521000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2624000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2624000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1290000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5846000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9607000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2471000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2471000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-153000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,134000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2320000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2320000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,211000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,119000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2327000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,337000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,337000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-504000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,549000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-55000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-55000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,282000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2484000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2484000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,215000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1064000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,805000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4568000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4568000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15174000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15140000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15140000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19708000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4207000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4207000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,232000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1414000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2262000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8115000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8115000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-53000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,525000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,472000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,472000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8587000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,32530000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32530000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,215000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-18998000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19463000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5716000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5716000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-55000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,473000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10000000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9582000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9582000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15291000.0
